Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
1.080
+0.030 (2.86%)
At close: May 12, 2025, 4:00 PM
1.040
-0.040 (-3.70%)
After-hours: May 12, 2025, 7:58 PM EDT
MBRX's stock price has decreased by -77.31% in the past year and price targets may not have had time to catch up.
Moleculin Biotech Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$6.00
Upside
+455.56%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $4 | Hold → Strong Buy | Upgrades | $4 | +270.37% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +640.74% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +640.74% | Mar 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +640.74% | Mar 3, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $20 → $8 | Strong Buy | Maintains | $20 → $8 | +640.74% | Nov 12, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $40 | Strong Buy | Maintains | $40 | +3,603.70% | Apr 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $20 | Strong Buy | Maintains | $45 → $20 | +1,751.85% | Mar 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +4,066.67% | Dec 14, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $240 | Strong Buy | Maintains | $240 | +22,122.22% | Apr 18, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $75 | Buy | Reiterates | $75 | +6,844.44% | Mar 24, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $30 → $210 | Buy | Initiates | $30 → $210 | +19,344.44% | Jul 18, 2022 |